Drug · DIN 01997653
DANTRIUM CAPSULES
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 13, 2017; first marketed December 31, 1993.
- Drug Identification Number (DIN)
- 01997653
- Company (DIN owner)
- Par Pharmaceutical CompaniesChestnut Ridge, New York, United States
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Dantrolene M03CA01
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DANTROLENE SODIUM | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 12, 2015: NOC 16684New Drug Submission (NDS) · Manufacturer name change
- January 21, 2015: NOC 16551New Drug Submission (NDS) · Merger - buyout
- December 18, 2008: NOC 9945New Drug Submission (NDS) · Manufacturer name change
Other DINs named DANTRIUM CAPSULES
- DIN 01997602 · Marketed